Lightstone Ventures this week said it raised $250 million for its second fund, $50 million more than it was aiming for. Menlo Park, Calif.- and Boston-based Lightstone said it plans to use the cash to back “companies developing therapies which have the potential to change the practice of medicine” and to found companies via its alliance […]
Nevro promotes prez Elghandour to replace CEO DeMane | Personnel Moves
Nevro Corp. (NYSE:NVRO) this week promoted president Rami Elghandour to be its new CEO, as chief executive Michael DeMane moves to the executive chairman spot. DeMane, the former COO at Medtronic, will keep an active role in Nevro, which he joined in 2011 after a quickly aborted stint at the head of Lanx. He’s due to […]
Claret Medical chases FDA win with $18M Series B for cerebral protection device
Claret Medical said today that it secured up to $18 million in Series B financing it plans to use to make progress toward the U.S. market.
GI Dynamics raises $32M in private placement with group overseas | Medtech funding stories for the week of May 5, 2014
Lightstone targets medtech and lifesciences with new $172M fund
Lightstone Ventures is ready to make some disruptive companies with its newly raised $172 million medtech and lifesciences fund, saying that market outlooks are promising for new products.
